PRESS
Here you can the latest press releases and selected information as well as images to support reporters and journalists in their work. If you need any further assistance please contact us directly.
PRESS RELEASES
October 2020
RCPE awarded two FDA contracts for next-generation pharma technology
RCPE has been awarded FDA funding for two projects commencing in the 4th quarter of 2020. The projects will focus on utilising advanced technologies to improve production processes within Pharma. With an average of only 5 – 10 projects awarded to EU companies by the FDA each year, this development represents a landmark achievement for RCPE and reflects the potential impact of these projects within the global pharma industry.
-
- RCPE Headquarter © RCPE
-
- Dr. Thomas Klein, Prof. Johannes Khinast © Lichtmeister Photography Productions
May 2020
COVID-19: Graz Chemists want to eliminate drug shortages using state-of-the-art technology
One of the most promising drugs against Covid-19, the disease that causes coronavirus, is Remdesivir. Researchers in Graz are currently testing a more efficient production method using flow chemistry.
May 2020
Coronavirus can’t stop the pharmaceutical location Styria!
Styria confirms its role as a first-class life science location and welcomes the international pharmaceutical company Grey Pharma GmbH.
-
- Foundation Grey Pharma GmbH © RCPE – Abdruck mit Copyright-Angabe honorarfrei
April 2020
The active ingredient alone does not solve the problem…
At present, hopes for a sustainable solution to the corona crisis rest on finding as quickly as possible suitable active ingredients for the treatment of patients and for preventive vaccination. However, it must also be possible to produce these active ingredients in the shortest possible time. With traditional methods, this process takes once again months. With the “high-speed technology” developed at RCPE, the production of new active ingredients can be massively accelerated.
-
- RCPE Pilotanlage frontal © Markus Trinkel – Print with copyright notice – free of charge
March 2020
Joerg Breitenbach Inducted into Medical and Biological Engineering Elite
The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Joerg Breitenbach, Ph.D., MBA, Founder and Scientific Advisor, BIT Pharma to its College of Fellows.
Dr. Breitenbach was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions in development and commercialization of patient centric polymer based dosage forms in infectious diseases and neurological interventions.” […]
October 2019
RCPE’s ConsiGmaTM CTL 25 Line is celebrating its first anniversary
Over the past 12 months our researchers have been working with multiple, large pharmaceutical companies, gaining experience and expertise on the transition from batch to continuous manufacturing (CM).
Thanks to a strategic partnership with GEA and our ConsiGmaTM CTL 25 line, we now have a deep understanding of CM processes: we know how the single units interact, where and why problems arise, and how to overcome them. […]
February 2018
RCPE and Perceptive Engineering solidify partnership to accelerate adoption of Advanced Process Controls
The Austrian based Research Center Pharmaceutical Engineering GmbH (RCPE), an independent R&D Center specialized in advanced manufacturing science and pharmaceutical engineering, and Perceptive Engineering Limited, leading provider for automated, advanced process control solutions, jointly announce the formation of a technology partnership to drive and accelerate the adoption of Advanced Process Control (APC) within the pharmaceutical industry. By combining excellent, complementary expertise, the companies can investigate, develop and offer integrated solutions to improve the precision, robustness and continuous process verification of pharmaceutical manufacturing systems. […]
Juli 2018
Neues Zeitalter in der personalisierten Medizin
Das Research Center Pharmaceutical Engineering GmbH (RCPE) baut seine Position als führendes Forschungszentrum im Bereich der personalisierten Medizin weiter aus. Die letztes Jahr eröffnete Pilotfabrik erhielt nun um rund 5 Millionen Euro eine Erweiterung. Mit der Consigma™ CTL 25 können in einer Kompakteinheit aus Pulver beschichtete Tabletten auch in Kleinmengen hergestellt werden – ideal für die Entwicklung von neuen Arzneimitteln und den dazugehörigen Produktionsprozessen. So können neue, auch personalisierte Medikamente rascher auf den Markt gebracht werden. […]
DOWNLOADS
IMAGES
CEOs
Headquarter
LEADING PHARMA INNOVATION